Literature DB >> 10022419

Differences in insulin resistance do not predict weight loss in response to hypocaloric diets in healthy obese women.

T McLaughlin1, F Abbasi, M Carantoni, P Schaaf, G Reaven.   

Abstract

The current study was initiated to determine whether insulin resistance and/or hyperinsulinemia affected the ability of obese individuals to lose weight in response to hypocaloric diets. Thirty-one obese, nondiabetic women, with values for body mass index ranging from 28.0-35.0 kg/m2, volunteered for this program. Resistance to insulin-mediated glucose disposal was assessed by determining their steady state plasma insulin and glucose concentration during the last 30 min of a 180-min infusion of somatostatin, insulin, and glucose. The total integrated insulin response to breakfast and lunch was also determined. After the baseline measurements, volunteers were placed on a hypocaloric diet calculated to lead to a minimum weekly loss of 1% of ideal body weight. Individuals who met the criteria after 30 days of dieting were defined as weight loss successes (n = 20) and continued on the diet for another 30 days. Individuals not meeting the criteria were designated as weight loss failures (n = 12) and were discharged from the study. There was a mean (+/-SEM) weight loss at 60 days of 9.2 +/- 0.4 kg in the 20 individuals defined as weight loss successes, but there was no correlation between weight loss and either steady state plasma glucose or the total integrated insulin response (r < 0.1; P > 0.83). Furthermore, using the same criteria to define insulin sensitivity and insulin resistance as those for therapeutic successes, the therapeutic failures comprised six insulin-sensitive and five insulin-resistant subjects. In summary, insulin-mediated glucose disposal varied widely in nondiabetic, obese women, and there was no relationship between baseline insulin resistance or total integrated insulin response and weight loss. It is concluded that the ability to lose weight on a calorie-restricted diet over a short time period does not vary in obese, healthy women as a function of insulin resistance or hyperinsulinemia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10022419     DOI: 10.1210/jcem.84.2.5441

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

Review 1.  Diet and Syndrome X.

Authors:  G M Reaven
Journal:  Curr Atheroscler Rep       Date:  2000-11       Impact factor: 5.113

Review 2.  Insulin resistance and polycystic ovary syndrome.

Authors:  David A Ehrmann
Journal:  Curr Diab Rep       Date:  2002-02       Impact factor: 4.810

3.  Prospective analyses of white adipose tissue gene expression in relation to long-term body weight changes.

Authors:  Kelvin H M Kwok; Mikael Rydén; Daniel P Andersson; Gallic Beauchef; Christelle Guere; Katell Vie; Otto Bergman; Veroniqa Lundbäck; Peter Arner; Ingrid Dahlman
Journal:  Int J Obes (Lond)       Date:  2019-06-04       Impact factor: 5.095

4.  Insulin resistance influences weight loss in non-obese women who followed a home-based exercise program and slight caloric restriction.

Authors:  Mauro Felippe Felix Mediano; Rosely Sichieri
Journal:  Diabetes Res Clin Pract       Date:  2011-04-03       Impact factor: 5.602

5.  Enhanced proportion of small adipose cells in insulin-resistant vs insulin-sensitive obese individuals implicates impaired adipogenesis.

Authors:  T McLaughlin; A Sherman; P Tsao; O Gonzalez; G Yee; C Lamendola; G M Reaven; S W Cushman
Journal:  Diabetologia       Date:  2007-06-05       Impact factor: 10.122

6.  Personalized Dietary Management of Overweight and Obesity Based on Measures of Insulin and Glucose.

Authors:  Mads F Hjorth; Yishai Zohar; James O Hill; Arne Astrup
Journal:  Annu Rev Nutr       Date:  2018-06-01       Impact factor: 9.323

7.  Effect on Insulin-Stimulated Release of D-Chiro-Inositol-Containing Inositolphosphoglycan Mediator during Weight Loss in Obese Women with and without Polycystic Ovary Syndrome.

Authors:  Kai I Cheang; Sakita N Sistrun; Kelley S Morel; John E Nestler
Journal:  Int J Endocrinol       Date:  2016-09-18       Impact factor: 3.257

Review 8.  Myths about Insulin Resistance: Tribute to Gerald Reaven.

Authors:  Sun H Kim; Fahim Abbasi
Journal:  Endocrinol Metab (Seoul)       Date:  2019-03

9.  Effect of weight reduction on metabolic syndrome in Korean obese patients.

Authors:  Hye Soon Park; Su Jung Sim; Jung Yul Park
Journal:  J Korean Med Sci       Date:  2004-04       Impact factor: 2.153

10.  The effect of orlistat versus metformin on body composition and insulin resistance in obese premenopausal women: 3-month randomized prospective open-label study.

Authors:  Magdalena Kujawska-Łuczak; Katarzyna Musialik; Monika Szulińska; Ewelina Swora-Cwynar; Angelina Kargulewicz; Małgorzata Grzymisławska; Danuta Pupek-Musialik; Paweł Bogdański
Journal:  Arch Med Sci       Date:  2016-08-29       Impact factor: 3.318

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.